CGTX

Conviction 14HealthcareScan · Thu, Jun 25, 2026

CGTX$1.13+10.29%

ResistanceSupportVol 14Insider buy

Vol MA14 2.14M

Mar 26Apr 14May 1May 19Jun 8Jun 25

COGNITION THERAPEUTICS INCBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.cogrx.com ↗

Price1.13

Change+10.29%

Gap+4.41%

Rel volume1.47×

Avg volume2.03M

Avg $ vol2.56M

SMA 201.29

SMA 501.24

SMA 2001.36

Price vs 50-9.28%

Price vs 200-17.11%

MA stackbearish

50/200 cross—

Supertrenddown · 1.69

RSI (14)44

MACD hist-0.01

MACD crossbear · 0d

Stoch %K / %D23 / 37

ADX (14)20

+DI / −DI22 / 29

RSI divergence—

MACD divergence—

ATR %+16.03%

ADR %13.60%

52w high3.18

52w low0.3000

From 52w high-64.62%

Above 52w low+275.00%

New 52w highNo

SqueezeOff

Bollinger width51.19%

%B0.25

Donchian pos22.56%

Donchian high1.76

Donchian low0.9400

AVWAP (52w high)1.74

vs AVWAP high-35.49%

AVWAP (52w low)1.26

vs AVWAP low-10.92%

OBV trendFlat

Chaikin MF (20)-0.15

Today vs 20d1.47×

Avg vol (14d)2.14M

Avg vol (20d)2.03M

Avg $ vol (20d)2.56M

Market cap100.69M

RS 3m (vs SPY)-19.53%

RS 6m (vs SPY)-41.50%

RS line new highNo

Trend template1/8

Technical rank19.0

1 week-20.77%

1 month-9.27%

3 months+1.35%

6 months-29.25%

1 year+275.00%

YTD-23.47%

P/E-4.29

P/B3.37

P/S—

P/FCF-4.09

EPS-0.3200

Div yield—

ROE-78.52%

ROA-64.99%

Debt/Eq—

Current5.92

EV/EBITDA-1.46

Gross margin—

Net margin—

Rev growth—

EPS growth30.86%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value69.56M

Revenue—

Net income-4.57M

Gross profit—

Free cash flow-24.59M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out89.5M

Employees14

ListedFri, Oct 8, 2021

Free float79.6M

Float %90.2%

Short interest6.42M

Days to cover7.7d

Short volume57.8%

Squeeze score60 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$0.06 · 3 est

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction14 / 100

Pattern quality—

Tech rank19.0 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.63

Support1.09

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CGTX

All disclosures →

No recent disclosed trades by Congress in CGTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CGTX · 8 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
RICHSTONE ELLEN B Director · Common Stock · 2026-06-17	Grant	25K	—	2026-06-17	2026-06-22
Wallace Peggy Director · Common Stock · 2026-06-17	Grant	25K	—	2026-06-17	2026-06-22
Monia Brett P Director · Common Stock · 2026-06-17	Grant	25K	—	2026-06-17	2026-06-22
Khattar Jack A. Director · Common Stock · 2026-06-17	Grant	25K	—	2026-06-17	2026-06-22
Fletcher Aaron G.L. Director · Common Stock · 2026-06-17	Grant	25K	—	2026-06-17	2026-06-22
Doyle John Brendan Chief Financial Officer · Common Stock · 2026-05-01	Tax	8.57K	$11K	2026-05-01	2026-05-04
Doyle John Brendan Chief Financial Officer · Common Stock · 2026-04-16	Buy	10K	$11K	2026-04-16	2026-04-20
Ricciardi Lisa CEO & President · Common Stock · 2026-04-16	Buy	9.18K	$10K	2026-04-16	2026-04-20
Caggiano Anthony Chief Medical Officer · Common Stock · 2026-04-16	Buy	10K	$11K	2026-04-16	2026-04-20
Ricciardi Lisa CEO & President · Common Stock · 2026-04-16	Other	—	—	2026-04-16	2026-04-20

SEC filings

EDGAR filings in CGTX · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.